A Network Science Approach to Sex-Polydrug Use Among Black Sexually Minoritized Men and Transgender Women: The N2 Cohort Study
- PMID: 38372856
- PMCID: PMC11588306
- DOI: 10.1007/s11121-023-01639-6
A Network Science Approach to Sex-Polydrug Use Among Black Sexually Minoritized Men and Transgender Women: The N2 Cohort Study
Abstract
Black sexually minoritized men (SMM) and transgender women (TW) are subgroups with lower rates of substance use and comparable rates of condom use relative to White SMM and TW yet experience heightened vulnerability to HIV. This study sought to explore associations of substance use, including sex-drug use (i.e., drug or alcohol use during sex to enhance sex), and condomless sex among Black SMM and TW. Data were collected from Black SMM and TW living in Chicago, Illinois, enrolled in the Neighborhoods and Networks (N2) cohort study, from November 2018 to April 2019. We used bivariate analyses followed by a multilevel egocentric network analysis to identify factors associated with condomless sex. We conducted Spearman correlation coefficients to examine correlations between pairs of sex-drugs to enhance sex. We used a bipartite network analysis to identify correlates of sex-drug use and condomless sex. A total of 352 Black SMM and TW (egos) provided information about 933 sexual partners (alters). Of respondents, 45% reported condomless sex and 61% reported sex-drug use. In unadjusted analyses, marijuana (34%) and cocaine/crack (5%) sex-drug use were associated with condomless sex (p < 0.05). Condomless sex was positively associated with sex-polydrug use, or the use of 2+ drugs or 1 drug and alcohol (OR = 1.48; 95% CI: 1.02-2.14; p = 0.039), and negatively associated with sharing an HIV-negative serostatus with a sexual partner (OR = 0.57; 95% CI: 0.33-0.98; p = 0.041), having a different HIV serostatus with a sexual partner (OR = 0.37; 95% CI: 0.21-0.64; p < 0.001) or not knowing the HIV serostatus of a sexual partner (OR = 0.47; 95% CI: 0.26-0.84; p = 0.011). The following pairs of sex-polydrug use had Spearman correlation coefficients higher than 0.3: marijuana and alcohol, ecstasy and alcohol, cocaine/crack and ecstasy, and methamphetamine and poppers (p < 0.05). HIV prevention interventions for Black SMM and TW designed to reduce HIV transmission through egocentric sexual networks could address sex-drug use through sex-positive and pleasure-centered harm reduction strategies and provide and promote biomedical prevention and care options at supraoptimal levels.
Keywords: Condom use; HIV prevention; Multilevel modeling; Polysubstance use; Sexual minority men.
© 2024. Society for Prevention Research.
Conflict of interest statement
Figures
References
-
- Borgatti SP, & Everett MG (1997). Network analysis of 2-mode data. Social Networks, 19(3), 243–269.
-
- Bourne A, Cassolato M, Thuan Wei CK, Wang B, Pang J, Lim SH, Azwa I, Yee I, & Mburu G (2017). Willingness to use pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM) in Malaysia: Findings from a qualitative study. Journal of the International AIDS Society, 20(1), 21899. - PMC - PubMed
MeSH terms
Grants and funding
- T32AI114398/National Institute of Allergy and Infectious Diseases
- K01 AA028199/AA/NIAAA NIH HHS/United States
- T32DA031099/DA/NIDA NIH HHS/United States
- T32 AI114398/AI/NIAID NIH HHS/United States
- T32MH019139/MH/NIMH NIH HHS/United States
- U01 PS005122/PS/NCHHSTP CDC HHS/United States
- R01MH112406/MH/NIMH NIH HHS/United States
- U2CDA050098/DA/NIDA NIH HHS/United States
- R25DA026401/DA/NIDA NIH HHS/United States
- U2C DA050098/DA/NIDA NIH HHS/United States
- R49 CE003094/CE/NCIPC CDC HHS/United States
- T32DA03109/DA/NIDA NIH HHS/United States
- U01PS005122/CC/CDC HHS/United States
- R49CE003096/CC/CDC HHS/United States
- R25 DA026401/DA/NIDA NIH HHS/United States
- R01DA054553/DA/NIDA NIH HHS/United States
- P30DA011041/DA/NIDA NIH HHS/United States
- P30 DA011041/DA/NIDA NIH HHS/United States
- R01 DA054553/DA/NIDA NIH HHS/United States
- R03 DA053161/DA/NIDA NIH HHS/United States
- R01 MH112406/MH/NIMH NIH HHS/United States
- T32 MH019139/MH/NIMH NIH HHS/United States
- K01 DA057880/DA/NIDA NIH HHS/United States
- R21 DA053156/DA/NIDA NIH HHS/United States
- T32 DA031099/DA/NIDA NIH HHS/United States
- R03DA053161/DA/NIDA NIH HHS/United States
- L60 DA054642/DA/NIDA NIH HHS/United States
- R21DA053156/DA/NIDA NIH HHS/United States
- K01AA028199/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous